Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Ohio State University Comprehensive Cancer Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Ohio State University Comprehensive Cancer Center brings 19 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2539. Its research spans acute myeloid leukemia, chronic lymphocytic leukemia and artificial intelligence for transplant outcomes. It covers a randomized trial of ASTX727 with standard versus shorter venetoclax.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
NCI-designated comprehensive cancer center of Ohio State University in Columbus, including its dedicated cancer hospital.
Booth
Exhibiting at Booth 2539
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies
Shared decision-making in chronic lymphocytic leukemia, using biomarker testing to choose among fixed-duration, continuous, and newer targeted treatments.
Symposium hosted by Decera Clinical Education
Lymphoma
Symposium
Fri Dec 11
11:00am–2:00pm
Decoding High-Risk AML: Applying Molecular Insights to Clinical Decision-Making
Using tests for isocitrate dehydrogenase and Flt3 mutations to guide targeted therapy choices in acute myeloid leukemia.
Leukemias
Symposium
Fri Dec 11
11:00am–2:00pm
Realigning Modern Care in MCL: Guidance on the Next Wave of Advances With BTK Inhibitor Options and New Targeted Strategies
Mantle cell lymphoma care built on Bruton tyrosine kinase inhibitors up front, with newer kinase and Bcl-2 inhibitors or CAR-T after relapse.
Symposium hosted by PeerView Institute for Medical Education
Lymphoma · New drugs
Symposium
Fri Dec 11
7:00pm–10:00pm
Cases and Conversations: Sequencing Strategies in Relapsed and Refractory CLL
Continuous kinase inhibitors versus fixed-duration Bcl-2 combinations for chronic lymphocytic leukemia, weighed against recent phase 3 trial results.
Lymphoma
Session
Sun Dec 13
11:30am–12:30pm
Treating Fairly Rounds Lunch
How hematologists and fellows can influence healthcare reform on research funding, Medicaid, and hospital budgets, and how policy shapes health inequities.
Patient care
Talk
Sun Dec 13
4:30pm–6:00pm
Practical Generative AI Tools for Clinicians and Investigators
A hands-on introduction to large language models for clinical and research work, from prompting to privacy concerns.
AI & data

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ohio State University Comprehensive Cancer Center

Tell us what you sell and we’ll find the people at Ohio State University Comprehensive Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction